Psychotropic dose equivalence in Japan
- PMID: 25601291
- DOI: 10.1111/pcn.12275
Psychotropic dose equivalence in Japan
Abstract
Psychotropic dose equivalence is an important concept when estimating the approximate psychotropic doses patients receive, and deciding on the approximate titration dose when switching from one psychotropic agent to another. It is also useful from a research viewpoint when defining and extracting specific subgroups of subjects. Unification of various agents into a single standard agent facilitates easier analytical comparisons. On the basis of differences in psychopharmacological prescription features, those of available psychotropic agents and their approved doses, and racial differences between Japan and other countries, psychotropic dose equivalency tables designed specifically for Japanese patients have been widely used in Japan since 1998. Here we introduce dose equivalency tables for: (i) antipsychotics; (ii) antiparkinsonian agents; (iii) antidepressants; and (iv) anxiolytics, sedatives and hypnotics available in Japan. Equivalent doses for the therapeutic effects of individual psychotropic compounds were determined principally on the basis of randomized controlled trials conducted in Japan and consensus among dose equivalency tables reported previously by psychopharmacological experts. As these tables are intended to merely suggest approximate standard values, physicians should use them with discretion. Updated information of psychotropic dose equivalence in Japan is available at http://www.jsprs.org/en/equivalence.tables/. [Correction added on 8 July 2015, after first online publication: A link to the updated information has been added.].
Keywords: antidepressant; antiparkinsonian drugs; antipsychotic; anxiolytic; dose equivalence; hypnotic.
© 2015 The Authors. Psychiatry and Clinical Neurosciences © 2015 Japanese Society of Psychiatry and Neurology.
Similar articles
-
Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.Clin Drug Investig. 2019 Nov;39(11):1077-1092. doi: 10.1007/s40261-019-00838-w. Clin Drug Investig. 2019. PMID: 31399894
-
Neurocognitive costs and benefits of psychotropic medications in older adults.J Geriatr Psychiatry Neurol. 2007 Dec;20(4):199-214. doi: 10.1177/0891988707308803. J Geriatr Psychiatry Neurol. 2007. PMID: 18004007
-
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.Clin Schizophr Relat Psychoses. 2011 Oct;5(3):124-34. doi: 10.3371/CSRP.5.3.2. Clin Schizophr Relat Psychoses. 2011. PMID: 21983496 Clinical Trial.
-
Psychotropic Drug Prescription in Children and Adolescents: Approved Medications in European Countries and the United States.J Child Adolesc Psychopharmacol. 2022 Mar;32(2):80-88. doi: 10.1089/cap.2021.0027. Epub 2022 Feb 9. J Child Adolesc Psychopharmacol. 2022. PMID: 35138922 Review.
-
Update on psychotropic medication use in renal disease.Psychosomatics. 2004 Jan-Feb;45(1):34-48. doi: 10.1176/appi.psy.45.1.34. Psychosomatics. 2004. PMID: 14709759 Review.
Cited by
-
Frontal pole-precuneus connectivity is associated with a discrepancy between self-rated and observer-rated depression severity in mood disorders: a resting-state functional magnetic resonance imaging study.Cereb Cortex. 2024 Jul 3;34(7):bhae284. doi: 10.1093/cercor/bhae284. Cereb Cortex. 2024. PMID: 39049465 Free PMC article.
-
Neuronal autoantibodies in the cerebrospinal fluid of 148 patients with schizophrenia and 151 healthy controls.Heliyon. 2024 May 5;10(10):e30695. doi: 10.1016/j.heliyon.2024.e30695. eCollection 2024 May 30. Heliyon. 2024. PMID: 38770306 Free PMC article.
-
Clinico-demographic factors associated with the treatment response to cognitive behavioral therapy for insomnia.Biopsychosoc Med. 2024 May 17;18(1):13. doi: 10.1186/s13030-024-00308-6. Biopsychosoc Med. 2024. PMID: 38760779 Free PMC article.
-
Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study.Psychiatry Investig. 2024 Mar;21(3):311-320. doi: 10.30773/pi.2023.0413. Epub 2024 Mar 25. Psychiatry Investig. 2024. PMID: 38569589 Free PMC article.
-
Alterations in subcortical magnetic susceptibility and disease-specific relationship with brain volume in major depressive disorder and schizophrenia.Transl Psychiatry. 2024 Mar 26;14(1):164. doi: 10.1038/s41398-024-02862-7. Transl Psychiatry. 2024. PMID: 38531856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials